Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)
Trademark/Service Mark Application, Principal Register
Photograph of the mark displayed on the product label affixed to the product container
INTERNATIONAL CLASS
001
*IDENTIFICATION
Kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of
cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes
Photograph of the mark displayed on the product label affixed to the product container
INTERNATIONAL CLASS
005
*IDENTIFICATION
Kits comprised of cells, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes; kits comprised of
cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes
Photograph of the mark displayed on the product label affixed to the product container
INTERNATIONAL CLASS
042
*IDENTIFICATION
Research in the field of cancer; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics
and research related thereto
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)
Trademark/Service Mark Application, Principal Register
Serial Number:87701224
Filing Date:11/29/2017
To the Commissioner for Trademarks:
MARK: NK-92 (Standard Characters, see mark)
The literal element of the mark consists of NK-92.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, NantKwest, Inc., a corporation of Delaware, having an address of
9920 Jefferson Boulevard
Culver City, California 90232
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 001: Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely,
natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research
In International Class 001, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/1994, and first used in
commerce at least as early as 00/00/1994, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) Photograph of the mark displayed on the product label affixed to the product container.
International Class 001: Kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits
comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes
In International Class 001, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/2008, and first used in
commerce at least as early as 00/00/2008, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) Photograph of the mark displayed on the product label affixed to the product container.
International Class 005: Cells for clinical, medical, veterinary, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived
preparations, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, veterinary, and therapeutic
purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes
In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/1994, and first used in
commerce at least as early as 00/00/1994, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) Photograph of the mark displayed on the product label affixed to the product container.
International Class 005: Kits comprised of cells, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes; kits
comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes
In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/2008, and first used in
commerce at least as early as 00/00/2008, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) Photograph of the mark displayed on the product label affixed to the product container.
International Class 042: Research in the field of cancer; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine,
therapeutics and research related thereto
In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/2005, and first used in
commerce at least as early as 00/00/2005, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) Printout from Applicant's website displaying the mark in connection with the services.
The applicant's current Attorney Information:
Alicia M. Passerin and Alan G. Towner, Michael D. Lazzara, Charles M. Yeomans, Christopher J. Owens of Leech Tishman Fuscaldo &
Lampl 525 William Penn Place, 28th Floor
Pittsburgh, Pennsylvania 15219
United States
412-261-1600(phone)
412-227-5551(fax)
ipdocket@leechtishman.com (authorized)
The attorney docket/reference number is NKW-19.
The applicant's current Correspondence Information:
Alicia M. Passerin
Leech Tishman Fuscaldo & Lampl
525 William Penn Place, 28th Floor
Pittsburgh, Pennsylvania 15219
412-261-1600(phone)
412-227-5551(fax)
ipdocket@leechtishman.com;apasserin@leechtishman.com; dpeake@leechtishman.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: /Alicia M. Passerin/ Date: 11/29/2017
Signatory's Name: Alicia M. Passerin
Signatory's Position: Attorney of Record, PA Bar Member
Payment Sale Number: 87701224
Payment Accounting Date: 11/29/2017
Serial Number: 87701224
Internet Transmission Date: Wed Nov 29 13:02:52 EST 2017
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XX-20171129130252602
511-87701224-510f36a5f3e7d60aac25728c1a7
f9675d97d0786057f7479260e14e4679c48784e-
DA-11807-20171129125553454517